Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
National Institute for Health and Care Excellence (NICE) benzodiazepines and z-drugs Mis-Diagnosis of Withdrawal Effects As Relapse The Context for Deprescribing antidepressants gabapentinoids Practical Options for Prescribing Gradually Tapering Doses The Neurobiology of Tapering
National Institute on Drug Abuse (NIDA) Mis-Diagnosis of Withdrawal Effects As Relapse Recent Developments in the Understanding of Antidepressant Withdrawal Physical Dependence vs Addiction in Use of Benzodiazepines and Z-Drugs
Neurobiology benzodiazepines and z-drugs Pathophysiology of Psychiatric Drug Withdrawal Symptoms antidepressants Mis-Diagnosis of Withdrawal Effects As Relapse The Neurobiology of Tapering
Neuromuscular disorders Clinical Aspects of Antidepressant Withdrawal Discussing Deprescribing Gabapentinoids Discussing Deprescribing Benzodiazepines and Z-Drugs Variety of Withdrawal Symptoms from Benzodiazepines and Z-Drugs
Neuropathic pain Tapering Gabapentinoids in Practice When and Why to Stop Gabapentinoids
Nitrazepam Nitrazepam Switching to Longer-Acting Benzodiazepines to Taper
N-methyl-d-aspartate (NMDA)
Nocebo effects Pathophysiology of Antidepressant Withdrawal Symptoms How Common, Severe and Long-Lasting are Withdrawal Symptoms from Antidepressants?
Noradrenaline Hyperbolic Tapering of Antidepressants Clinical Aspects of Antidepressant Withdrawal Recent Developments in the Understanding of Antidepressant Withdrawal
Nortriptyline
Nutritional supplements Other Considerations in Tapering Gabapentinoids Other Considerations in Tapering Benzodiazepines and Z-Drugs